In recent days, assisted reproduction concept stocks have been quite active. As of the closing on March 10, several related stocks rose strongly. People from relevant listed companies told the financial associated press that the inclusion of multiple assisted reproductive technologies in medical insurance in Beijing, the supporting measures on improving the three child policy during the two sessions and the proposal on assisted reproduction at the two sessions have all been good for the industry. Assisted reproduction is also dancing in the context of encouraging fertility.
“The introduction of relevant policies and the proposals of the two sessions will greatly help the future market potential and development space of the whole field of assisted reproduction. I personally believe that at present, we are still solving the problem of enabling families with reproductive intention to have access to the medical service resources of assisted reproduction at a lower cost.” An industry source told the financial associated press.
A securities analyst told the financial associated press that with the introduction of the three child policy and other fertility related policies, the rise of infertility rate and the increase of China’s per capita disposable income, the penetration rate of assisted reproduction in China is expected to increase in the future. According to Galaxy Securities, in 2018, about 568000 patients in China received assisted reproductive services, accounting for only 1.2% of 47.8 million infertile couples in the same year. The penetration rate of assisted reproductive services in China was only 7% in 2018, far lower than 30.2% in the United States in the same period.
(Note: comparison of penetration rate of assisted reproduction between China and the United States, from frost Sullivan, China Galaxy Securities Co.Ltd(601881) Securities Research Institute)
It is worth mentioning that Beijing has recently incorporated 16 assisted reproductive technologies into class a medical insurance, including two IUI (artificial insemination) technologies (semen cryoresuscitation, intrauterine artificial insemination) One second-generation IVF technique (intracytoplasmic sperm injection of oocytes) and three third-generation IVF techniques (diagnosis of embryo monogenic disease, preimplantation embryo genetic detection of chromosome diseases, blastocyst, blastomere and polar body biopsy). The above analysts believe that this shows the government’s attention to reproductive support. In the future, assisted reproductive technology is expected to receive payment end support in a wider range, and the industry penetration is expected to increase rapidly.
From the perspective of listed companies, according to the company’s annual report, Everjoy Health Group Co.Ltd(002162) ( Everjoy Health Group Co.Ltd(002162) . SZ) through self construction + extension M & A, its subsidiaries include American Rixing reproductive CITIC, Yichun maternity and reproduction cooperation project, etc Topchoice Medical Co.Inc(600763) ( Topchoice Medical Co.Inc(600763) . SH) introduces the Y chromosome microdeletion detection kit independently developed by Bonn reproductive center and Guangdong Hybribio Biotech Co.Ltd(300639) ( Guangdong Hybribio Biotech Co.Ltd(300639) . SH), which can detect and determine the etiology of infertile patients such as oligospermia, asthenospermia and oligospermia; Jiachen hospital under Dajia Weikang (301126. SZ) can carry out diagnosis and treatment of assisted reproduction related technologies. From the perspective of medical institutions, Jinxin reproduction (01951. HK) is one of the leaders in this field.
From the perspective of technological iteration, the above-mentioned people in the industry told the financial Associated Press: “assisted reproductive technology is divided into one, two and three generations. One generation takes sperm and eggs and mixes them into the test tube. The second generation is generally single crystal injection reproductive technology, and the third generation does genetic testing before embryo implantation. The purpose of the third generation assisted reproductive technology is to select a healthier baby.” The person also said that although the current demand for assisted reproduction in China lies more in the first and second-generation assisted reproduction technologies, the corresponding demand will rise with the attention paid to the quality of assisted reproduction and the clearer understanding of people with self gene carrying status, and the support of superimposed policies for the third-generation assisted reproduction technologies.
For listed companies, “keyun’an” or preimplantation genetic testing (PGT) under Berry Genomics Co.Ltd(000710) ( Berry Genomics Co.Ltd(000710) . SZ) is the third generation of assisted reproductive technology; Beikang medical (02170. HK) has three generations of test tube PGs test kits Bgi Genomics Co.Ltd(300676) ( Bgi Genomics Co.Ltd(300676) . SZ) is also laying out a series of products for gene testing before embryo implantation.
On the disk, as of the closing on March 10, assisted reproduction (bk0939) closed at 120341, up 4.88% Guangdong Hybribio Biotech Co.Ltd(300639) , Dajia Weikang, Xilong Scientific Co.Ltd(002584) ( Xilong Scientific Co.Ltd(002584) . SZ), Changchun High And New Technology Industries (Group) Inc(000661) ( Changchun High And New Technology Industries (Group) Inc(000661) . SH) and other stocks rose strongly.
